Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 225 Information Technology 205 Industrials 84 Consumer Discretionary 60 Financials 53 Communication Services 32 Materials 28 Consumer Staples 12 Energy 9 Real Estate 1 Utilities 1

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 135 Healthcare Equipment & Supplies 30 Pharmaceuticals 28 Life Sciences Tools & Services 18 Healthcare Providers & Services 8 Health Care Technology 6
Curated industry list

High-Beta Stocks in Biotechnology on NASDAQ

Explore High-Beta Stocks in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Achieve Life Sciences Inc (ACHV)
Fair Value-38.2% Downside Overvalued Analyst111.6% Upside Market Cap664.2 M P/E-13.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Alterity Therapeutics Ltd (ATHE)
Fair Value9.0% Upside Fair Analyst189.9% Upside Market Cap85.198 M P/E-8.3x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks
Altimmune Inc (ALT)
Fair Value-19.9% Downside Overvalued Analyst468.4% Upside Market Cap597 M P/E-6.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Arrowhead Pharmaceuticals Inc (ARWR)
Fair Value-10.9% Downside Fair Analyst25.7% Upside Market Cap12.655 B P/E-40.8x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Coherus BioSciences Inc (CHRS)
Fair Value9.3% Upside Fair Analyst437.9% Upside Market Cap228.3 M P/E-1.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Ironwood Pharmaceuticals Inc (IRWD)
Fair Value39.2% Upside Undervalued Analyst53.4% Upside Market Cap709.5 M P/E6.7x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Kazia Therapeutics Ltd ADR (KZIA)
Fair Value-20.1% Downside Overvalued Analyst132.6% Upside Market Cap140.7 M P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
MannKind Corp (MNKD)
Fair Value5.8% Upside Fair Analyst95.5% Upside Market Cap1.265 B P/E-55.3x Yield0.0% HealthGood
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks Small-Cap Stocks
Myriad Genetics Inc (MYGN)
Fair Value47.6% Upside Undervalued Analyst68.9% Upside Market Cap303.2 M P/E-2.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Novavax Inc (NVAX)
Fair Value-8.4% Downside Fair Analyst83.1% Upside Market Cap1.26 B P/E-14.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Oncolytics Biotech Inc (ONCY)
Fair Value0.2% Upside Fair Analyst537.5% Upside Market Cap96.736 M P/E-2.9x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Rigel Pharmaceuticals Inc (RIGL)
Fair Value6.9% Upside Fair Analyst36.3% Upside Market Cap716 M P/E2.3x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Agios Pharm (AGIO)
Fair Value21.7% Upside Undervalued Analyst43.1% Upside Market Cap1.887 B P/E-4.6x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Aldeyra The (ALDX)
Fair Value1.0% Upside Fair Analyst312.5% Upside Market Cap93.498 M P/E-3.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Anavex Life Sciences Corp (AVXL)
Fair Value-1.5% Downside Fair Analyst524.0% Upside Market Cap291.9 M P/E-8.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Arcturus Therapeutics Holdings Inc (ARCT)
Fair Value21.5% Upside Undervalued Analyst229.1% Upside Market Cap176.8 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Ardelyx Inc (ARDX)
Fair Value11.8% Upside Fair Analyst231.6% Upside Market Cap1.238 B P/E-20.9x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Benitec Biopharma Ltd ADR (BNTC)
Fair Value-22.5% Downside Overvalued Analyst90.4% Upside Market Cap430.1 M P/E-10.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Cardiff Oncology Inc (CRDF)
Fair Value21.6% Upside Undervalued Analyst446.0% Upside Market Cap63.509 M P/E-1.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Crescent Biopharma Inc (CBIO)
Fair Value-24.2% Downside Overvalued Analyst94.0% Upside Market Cap701.1 M P/E-4.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Eledon Pharmaceuticals Inc (ELDN)
Fair Value-6.9% Downside Fair Analyst161.6% Upside Market Cap269.8 M P/E-3.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum
Fate Therapeutics Inc (FATE)
Fair Value-6.3% Downside Fair Analyst108.1% Upside Market Cap299.6 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Heron Therapeuti (HRTX)
Fair Value96.0% Upside Bargain Analyst298.4% Upside Market Cap96.816 M P/E-3.1x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Ibio Inc (IBIO)
Fair Value6.2% Upside Fair Analyst287.1% Upside Market Cap72.531 M P/E-2.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Inovio Pharmaceuticals Inc (INO)
Fair Value18.2% Upside Undervalued Analyst308.7% Upside Market Cap54.555 M P/E-0.7x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Karyopharm Therapeutics Inc (KPTI)
Fair Value13.5% Upside Fair Analyst235.1% Upside Market Cap44.419 M P/E-0.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Minerva Neurosciences Inc (NERV)
Fair Value-16.3% Downside Fair Analyst118.4% Upside Market Cap188.2 M P/E-0.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Neurogene Inc (NGNE)
Fair Value-13.6% Downside Fair Analyst127.4% Upside Market Cap685.7 M P/E-7.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Savara Inc (SVRA)
Fair Value3.0% Upside Fair Analyst98.5% Upside Market Cap1.372 B P/E-10.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Travere Therapeutics Inc (TVTX)
Fair Value-4.0% Downside Fair Analyst8.9% Upside Market Cap5.281 B P/E-78.0x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Momentum Stocks High-Beta Momentum
TuHURA Biosciences Inc (HURA)
Fair Value-25.3% Downside Overvalued Analyst261.2% Upside Market Cap133.1 M P/E-4.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Ultragenyx (RARE)
Fair Value39.7% Upside Undervalued Analyst112.0% Upside Market Cap2.537 B P/E-4.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Uniqure NV (QURE)
Fair Value-19.5% Downside Overvalued Analyst57.5% Upside Market Cap3.03 B P/E-12.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Verastem Inc (VSTM)
Fair Value18.5% Upside Undervalued Analyst154.2% Upside Market Cap510.5 M P/E-2.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Abeona Therapeutics Inc (ABEO)
Fair Value6.8% Upside Fair Analyst189.9% Upside Market Cap388.7 M P/E5.9x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks
Adicet Bio Inc (ACET)
Fair Value32.0% Upside Undervalued Analyst280.3% Upside Market Cap96.715 M P/E-0.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Atara Biotherapeutics Inc (ATRA)
Fair Value0.6% Upside Fair Analyst60.0% Upside Market Cap79.019 M P/E-8.1x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks
Avalo Therapeutics Inc (AVTX)
Fair Value-7.3% Downside Fair Analyst137.2% Upside Market Cap980.3 M P/E-11.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks
Cartesian Therapeutics Inc (RNAC)
Fair Value5.5% Upside Fair Analyst314.0% Upside Market Cap236.8 M P/E-1.6x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Crispr Therapeutics AG (CRSP)
Fair Value-21.6% Downside Overvalued Analyst66.2% Upside Market Cap5.131 B P/E-11.2x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Cue Biopharma (CUE)
Fair Value15.0% Upside Fair Analyst333.6% Upside Market Cap111.7 M P/E-5.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Editas Medicine Inc (EDIT)
Fair Value-1.6% Downside Fair Analyst117.4% Upside Market Cap425.1 M P/E-3.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Fennec Pharmaceuticals Inc (FENC)
Fair Value12.7% Upside Fair Analyst48.9% Upside Market Cap351.2 M P/E-43.6x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum High-Growth Small-Cap Stocks Small-Cap Stocks
Forum Markets, Inc (FRMM)
Fair Value51.8% Upside Bargain Analyst52.5% Upside Market Cap77.147 M P/E-0.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Immunitybio Inc (IBRX)
Fair Value1.4% Upside Fair Analyst75.6% Upside Market Cap7.366 B P/E-7.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Indaptus Therapeutics Inc (INDP)
Fair Value-33.6% Downside Overvalued Analyst651.9% Upside Market Cap154 M P/E-8.0x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
InflaRx N.V. (IFRX)
Fair Value-37.9% Downside Overvalued Analyst326.0% Upside Market Cap262.2 M P/E-5.3x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Insight Molecular Diagnostics Inc (IMDX)
Fair Value18.0% Upside Fair Analyst66.7% Upside Market Cap165.3 M P/E-3.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Intellia Therapeutics Inc (NTLA)
Fair Value10.3% Upside Fair Analyst136.5% Upside Market Cap1.582 B P/E-3.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
OUTLOOK THERAPEUTICS INC (OTLK)
Fair Value-21.6% Downside Overvalued Analyst424.3% Upside Market Cap179.6 M P/E-3.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Explore listed stocks on NASDAQ with company information and fair value data.